<DOC>
	<DOCNO>NCT01454154</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , multi-institutional study IV RP-1127 ( Glyburide Injection ) begin within 10 hour complicate mild , moderate severe traumatic brain injury ( TBI ) .</brief_summary>
	<brief_title>Glyburide ( RP-1127 ) Traumatic Brain Injury ( TBI )</brief_title>
	<detailed_description>The primary efficacy objective study ass whether patient severe , moderate , complicate mild TBI administer RP-1127 show decrease MRI-defined edema and/or hemorrhage , compare patient administer placebo . The primary safety objective ass safety tolerability RP-1127 compare placebo patient severe , moderate , complicate mild TBI .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>1 . Documented closed head TBI 2 . Clearly defined time injury 10 hour administration study drug/placebo 3 . GCS 414 . The GCS obtain free effect sedate and/or paralytic drug . Complicated mild must GCS 1314 one following : Intraparenchymal clot contusion aggregate &gt; 10cc ; Midline shift &gt; 5mm ; IVH , SDH , EDH see one CT scan slice . 4 . Age 1875 year 5 . Patients dedicated peripheral IV line place study drug administration 6 . Written consent obtain legally authorize representative ( LAR ) 1 . No documented TBI time impact certain 2 . Penetrating brain injury 3 . Spinal column instability and/or spinal cord injury neurodeficit 4 . Concomitant severe non survivable injury 5 . Pregnant , positive pregnancy test 6 . Women intend breastfeed Study Days 14 . 7 . Blood glucose &lt; 50mg/dL 8 . Severe renal disorder patient 's history ( e.g . dialysis ) serum creatinine &gt; 2.5 mg/dL 9 . Severe liver disease total bilirubin &gt; 1.5 time upper limit normal 10 . INR &gt; 1.4 11 . Systolic BP &lt; 90 mm Hg responsive fluid resuscitation 12 . Blood alcohol &gt; 250mg/dL 13 . Inability MRI ( pacemaker , nonMR compatible pressure monitor , etc . ) 14 . Hospitalization brain injury , psychiatric neurological disease within previous 3 year 15 . Emergent urgent surgical operation anticipate ( OR , bedside procedure exclude ) would prevent dose study drug within 8 hour injury . 16 . Known use Coumadin ( warfarin ) , Plavix ( clopidogrel ) , Effient ( prasugrel ) Pletal ( cilostazol ) , heparin , low molecular weight heparin , heparinoids , abciximab similar antiplatelet agent previous 72 hour ( Note patient later find take medication automatically exclude study . ) 17 . Use sulfonylurea drug within prior 30 day 18 . Treatment another investigational drug within prior 30 day 19 . Allergy sulfonylurea drug 20 . Known diagnosis G6PD enzyme deficiency 21 . PaO2 &lt; 60 mm Hg admission ( patient blood gas draw per standard care ) 22 . NonEnglish speak legally authorize representative subject ( University Maryland ) 23 . Prisoners others may unable make truly voluntary uncoerced decision whether participate study 24 . Any clinical condition opinion investigator make patient unsuitable inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>TBI</keyword>
	<keyword>Traumatic Brain Injury</keyword>
</DOC>